PCRB vs. MYCI

Last updated Jun 4, 2026

PCRB (Putnam ESG Core Bond ETF -) and MYCI (State Street My2029 Corporate Bond ETF) are both exchange-traded funds - PCRB is a Intermediate Core Bond fund actively managed by Putnam, while MYCI is a Corporate Bonds fund actively managed by State Street. Both are actively managed. Over the past year, PCRB returned 4.53% vs 4.75% for MYCI. Their correlation of 0.86 suggests significant overlap in exposure. PCRB charges 0.35%/yr vs 0.15%/yr for MYCI.

Performance

PCRB vs. MYCI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Putnam ESG Core Bond ETF - (PCRB) and State Street My2029 Corporate Bond ETF (MYCI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PCRB achieves a -0.32% return, which is significantly lower than MYCI's 0.45% return.

PCRB

• 1D: -0.13%
• 1M: -0.22%
• YTD: -0.32%
• 6M: -0.43%
• 1Y: 4.53%
• 3Y*: 4.09%
• 5Y*: —
• 10Y*: —

MYCI

• 1D: -0.04%
• 1M: 0.17%
• YTD: 0.45%
• 6M: 0.87%
• 1Y: 4.75%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PCRB vs. MYCI - Yearly Performance Comparison

	2026 (YTD)	2025	2024
PCRB Putnam ESG Core Bond ETF -	-0.32%	7.21%	-3.25%
MYCI State Street My2029 Corporate Bond ETF	0.45%	7.59%	-1.56%

Correlation

The correlation between PCRB and MYCI is 0.87, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.87
Correlation (All Time) Calculated using the full available price history since Sep 25, 2024	0.86

The correlation between PCRB and MYCI has been stable across timeframes, ranging from 0.86 to 0.87 - a consistent structural relationship.

Return for Risk

PCRB vs. MYCI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCRB

PCRB Risk / Return Rank: 33
PCRB Sharpe Ratio Rank: 34
PCRB Sortino Ratio Rank: 35
PCRB Omega Ratio Rank: 31
PCRB Calmar Ratio Rank: 31
PCRB Martin Ratio Rank: 33

MYCI

MYCI Risk / Return Rank: 67
MYCI Sharpe Ratio Rank: 66
MYCI Sortino Ratio Rank: 72
MYCI Omega Ratio Rank: 71
MYCI Calmar Ratio Rank: 62
MYCI Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCRB vs. MYCI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Putnam ESG Core Bond ETF - (PCRB) and State Street My2029 Corporate Bond ETF (MYCI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PCRB	MYCI	Difference
Sharpe ratio: Return per unit of total volatility	1.21	2.15	-0.95
Sortino ratio: Return per unit of downside risk	1.84	3.22	-1.37
Omega ratio: Gain probability vs. loss probability	1.21	1.42	-0.21
Calmar ratio: Return relative to maximum drawdown	1.51	3.05	-1.54
Martin ratio: Return relative to average drawdown	4.90	11.23	-6.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PCRB vs. MYCI - Sharpe Ratio Comparison

The current PCRB Sharpe Ratio is 1.21, which is lower than the MYCI Sharpe Ratio of 2.15. The chart below compares the historical Sharpe Ratios of PCRB and MYCI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PCRB	MYCI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.21	2.15	-0.95
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	1.24	-0.65

Drawdowns

PCRB vs. MYCI - Drawdown Comparison

The maximum PCRB drawdown since its inception was -7.20%, which is greater than MYCI's maximum drawdown of -2.41%. Use the drawdown chart below to compare losses from any high point for PCRB and MYCI.

Drawdown Indicators

	PCRB	MYCI	Difference
Max Drawdown Largest peak-to-trough decline	-7.20%	-2.41%	-4.79%
Max Drawdown (1Y) Largest decline over 1 year	-3.02%	-1.56%	-1.46%
Max Drawdown (3Y) Largest decline over 3 years	-5.85%	—	—
Current Drawdown Current decline from peak	-2.18%	-0.56%	-1.62%
Average Drawdown Average peak-to-trough decline	-1.64%	-0.54%	-1.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.93%	0.42%	+0.51%

Volatility

PCRB vs. MYCI - Volatility Comparison

Putnam ESG Core Bond ETF - (PCRB) has a higher volatility of 1.32% compared to State Street My2029 Corporate Bond ETF (MYCI) at 0.59%. This indicates that PCRB's price experiences larger fluctuations and is considered to be riskier than MYCI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PCRB	MYCI	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.32%	0.59%	+0.73%
Volatility (6M) Calculated over the trailing 6-month period	2.66%	1.50%	+1.16%
Volatility (1Y) Calculated over the trailing 1-year period	3.77%	2.22%	+1.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	5.63%	3.02%	+2.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	5.63%	3.02%	+2.61%

PCRB vs. MYCI - Expense Ratio Comparison

PCRB has a 0.35% expense ratio, which is higher than MYCI's 0.15% expense ratio.

Dividends

PCRB vs. MYCI - Dividend Comparison

PCRB's dividend yield for the trailing twelve months is around 9.79%, more than MYCI's 4.57% yield.

Position	TTM	2025	2024	2023
MYCI State Street My2029 Corporate Bond ETF	4.57%	4.56%	1.19%	0.00%
PCRB Putnam ESG Core Bond ETF -	9.79%	4.30%	4.38%	3.65%

Frequently Asked Questions

Can I hold both PCRB and MYCI in my portfolio?

PCRB and MYCI have a correlation of 0.87, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PCRB or MYCI?

PCRB has higher volatility (1.32%) compared to MYCI (0.59%). In terms of maximum drawdown, PCRB dropped -7.20% vs MYCI's -2.41%.

Which ETF is better, PCRB or MYCI?

On 1-year performance, MYCI leads with 4.75% vs 4.53% for PCRB. On fees, MYCI is cheaper at 0.15% per year. On volatility, MYCI has been the lower-risk option at 0.59%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, PCRB or MYCI?

Over the 1-year period, MYCI has performed better with a 4.75% return vs 4.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, PCRB or MYCI?

MYCI is cheaper with a 0.15% expense ratio, compared with 0.35% for PCRB.

Which ETF pays a higher dividend yield, PCRB or MYCI?

PCRB has the higher dividend yield at 9.79%, compared with 4.57% for MYCI.

What is the main difference between PCRB and MYCI?

PCRB is categorized as Intermediate Core Bond, while MYCI is Corporate Bonds. They also come from different issuers: Putnam and State Street. Their fees differ too: 0.35% for PCRB and 0.15% for MYCI.

Which has better risk-adjusted returns?

MYCI currently has the higher Sharpe Ratio (2.15 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.